dka final
TRANSCRIPT
![Page 1: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/1.jpg)
Diabetic Ketoacidosis
EPU Team (Dr. Uko P., Dr. Eke E.P., Dr. Jemide O., Dr. Osang S.)
FMC Keffi
28th of May, 2014
![Page 2: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/2.jpg)
Outline
Overview of Diabetic Mellitus Diabetic Ketoacidosis: Introduction Epidemiology Physiology Pathophysiology Clinical Presentation Diagnosis Complications Treatment/Monitoring Prevention Conclusion References 2
![Page 3: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/3.jpg)
Overview of Diabetes Mellitus
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycaemia resulting from defects in insulin secretion, insulin action or both.
![Page 4: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/4.jpg)
Criteria for diagnosis
Symptoms of DM and casual plasma glucose conc. > 11.1mmol/L(200mg/dl) (10 for venous)
Fasting Plasma Glucose > 7.0mmol/L (126mg/dl) (6.3 for venous and capillary)
2hr post load of glucose >11.1mmol/L during an OGTT
![Page 5: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/5.jpg)
Types of DM
1. Type 1 Diabetes Mellitus (T1DM):- β cell destruction leading to absolute insulin deficiency. Immune mediated, idiopathic
2. Type 2 Diabetes Mellitus (T2DM):- insulin resistance with relative insulin deficiency
3. Other types Gestational DM
![Page 6: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/6.jpg)
Genetic defects of ◦β cell function◦Insulin action
Diseases of the pancreasEndocrinopathiesInfectionsDrug or chemical inducedGenetic syndromesUncommon forms of immune related
![Page 7: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/7.jpg)
TYPE 1 DM
Type 1 DM is the most common endocrine metabolic disorder of childhood and adolescence.
Autoimmune mechanisms are factors in the genesis of T1DM.
• Most cases are primarily due to T-cell mediated pancreatic islet β-cell destruction.
![Page 8: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/8.jpg)
Serological markers of an autoimmune pathologic process, including islet cell, glutamic acid decarboxylase (GAD), islet antigen (IA)-2, IA-2b, or insulin autoantibodies (IAAs), are present in 85–90% of individuals when fasting hyperglycaemia is detected
8
![Page 9: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/9.jpg)
Etiology of T1Diabetes
EnvironmentalFactors
•Cow’s milk?•Viruses ?•Nitrates?
Genetic Susceptibility•DM1: HLADR3,DR4↑•Protective DRB1,DQB1↓•DM2
Autoimmunity & Insulitis
Destruction of pancreatic β cells
![Page 10: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/10.jpg)
EPIDEMIOLOGY
T1DM accounts for about 10% of all diabetes,
affecting 1.4million in the USA and over 15million
in the world.
While it accounts for most cases of diabetes in
childhood, it is not limited to this age group; new
cases continue to occur in adult life and
approximately 50% of individuals with T1DM
present as adults.
![Page 11: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/11.jpg)
The incidence of type 1 DM is highly variable among different ethnic groups.
Girls and boys are almost equally affected but there is a modest female preponderance in some low risk populations (e.g the Japanese).
There is no apparent correlation with socioeconomic status.
![Page 12: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/12.jpg)
Peaks of presentation occur in 2 age groups: at 5-7 years of age and at the time of puberty.
The first peak may correspond to the time of increased exposure to the infectious agents coincident with the beginning of school;
![Page 13: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/13.jpg)
The 2nd peak may correspond to the pubertal growth spurt induced by gonadal steroids and the increased pubertal growth hormone secretion( which antagonizes insulin).
These possible cause-and-effect relationships remain to be proved.
13
![Page 14: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/14.jpg)
Morbidity and mortality stem from acute metabolic derangement and long-term complications (usually in adulthood) that affect small and large vessels resulting in retinopathy, nephropathy, neuropathy, ischaemic heart disease and arterial obstruction with gangrene of the extremities.
![Page 15: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/15.jpg)
The acute clinical manifestations are due to hypoinsulinaemic hyperglycaemic ketoacidosis.
Individuals with TIDM confront serious lifestyle alteration that include an absolute daily requirement for exogenous insulin, the need to monitor their own glucose level, and the need to pay attention to dietary intake.
15
![Page 16: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/16.jpg)
Predisposing Factors for T1DM
The major histo-compatibility complex on chromosome 6 – greatest contribution
Viral infections: Congenital rubella syndrome, Enteroviruses, Mumps virus.
Diet: Breast-feeding may lower the risk of T1DM either directly or by delaying exposure to cow’s milk protein.
![Page 17: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/17.jpg)
Hygiene Hypothesis: Possible protective role of infections. Lack of exposure to childhood infections may somehow increase an individual’s chances of developing autoimmune diseases including T1DM.
Psychologic stress
![Page 18: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/18.jpg)
T2DM
Heterogenous disorder characterized by peripheral resistance and failure of the β-cell to keep up with increasing insulin demand.
These patients have relative rather than absolute insulin deficiency.
Generally they are not ketosis prone, but ketoacidosis may develop in some circumstances.
Aetiology is not known, but these patients do not have autoimmune destruction of β-Cell nor do they have any of the known causes of secondary diabetes mellitus.
![Page 19: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/19.jpg)
DKA: INTRODUCTION
Diabetic ketoacidosis (DKA) is a metabolic derangement caused by the absolute or relative deficiency of insulin
It is one of the most important causes of mortality and severe morbidity in children with diabetes, particularly at the time of first diagnosis.
Early recognition and careful management are essential if death and disability are to be avoided
19
![Page 20: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/20.jpg)
HISTORY
The first full description of diabetic ketoacidosis is attributed to Julius Dreschfeld, a German pathologist working in Manchester, United Kingdom in 1886
The condition remained almost universally fatal until the discovery of insulin in the 1920s;
20
![Page 21: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/21.jpg)
Insulin was first isolated from the pancreas in 1922 by Banting and Best.
The entity of cerebral oedema due to DKA was described in 1936 by a team of doctors from Philadelphia.
21
![Page 22: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/22.jpg)
EPIDEMIOLOGY
Few data are availableIn the United Kingdom national study,
60% of all cases occurred in patients with known diabetes
In the USA, 25% of new cases of Type 1 DM present with ketoacidosis, approximate incidence of 4 per 100,000 children annually.
22
![Page 23: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/23.jpg)
88% of patients first present in the children's emergency room with Diabetic ketoacidosis (DKA) (Ugochi Ibekwe et al, Federal Teaching Hospital Abakaliki)
DKA has been found in the range of 7-80% in newly diagnosed patients and 25-90% in children who have already been diagnosed with diabetes.
This high prevalence of DKA is attributed to the lack of awareness among health workers and the community at large (Adesiyan et al) 23
![Page 24: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/24.jpg)
In FMC Keffi:From January 2013 to May 2014, a total of 6 patients were admitted for DKA5 females and 1 maleAge range: 8-11years (except the male, 3years 9months)2 cases were admitted in May 2014
24
![Page 25: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/25.jpg)
Sex: Although no difference in DKA rates exists between the sexes at diagnosis and during early childhood, adolescent girls with diabetes are twice as likely to develop DKA as adolescent boys.
Age: – Preschool aged children are at greatest risk of
presenting with DKA because the diagnosis of diabetes in children is often missed.
– Adolescents are more likely to develop DKA after diagnosis of diabetes 25
![Page 26: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/26.jpg)
PHYSIOLOGY
Insulin is a polypeptide containing two chains of amino acids linked by disulfide bridges
The net effect of the hormone is storage of carbohydrate, protein, and fat. Therefore, insulin is appropriately called the “hormone of abundance”
26
![Page 27: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/27.jpg)
Rapid (seconds) Increased transport of glucose, amino acids, and K+ into insulin-sensitive cells Intermediate (minutes) Stimulation of protein synthesis Inhibition of protein degradation Activation of glycolytic enzymes and glycogen synthase Inhibition of phosphorylase and gluconeogenic enzymes
Delayed (hours) Increase in mRNAs for lipogenic and other enzymes
Principal Actions of Insulin
27
![Page 28: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/28.jpg)
Insulin inactivates liver phosphorylaseIncreases the activity of the enzyme
glucokinase which causes the initial phosphorylation of glucose after it diffuses into the liver cells.
Increases the activity of glycogen synthase
Insulin inhibits the action of hormone-sensitive lipoprotein lipase 28
![Page 29: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/29.jpg)
Adipose tissue Increased glucose entry Increased fatty acid synthesis Increased glycerol phosphate synthesis Increased triglyceride deposition Inactivation of lipoprotein lipase Inhibition of hormone-sensitive lipase Increased K+ uptake
Effects of Insulin on Various Tissues
29
![Page 30: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/30.jpg)
Increased glucose entry Increased glycogen synthesis Increased amino acid uptake Increased protein synthesis in ribosomes Decreased protein catabolism Decreased release of gluconeogenic
amino acids Increased ketone uptake Increased K+ uptake
Muscle
30
![Page 31: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/31.jpg)
Decreased ketogenesis Increased protein synthesis Increased lipid synthesis Decreased glucose output due to decreased
gluconeogenesis, increased glycogen synthesis, and increased glycolysis
General Increased cell growth
Liver
31
![Page 32: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/32.jpg)
INFLUENCE OF FEEDING (HIGH INSULIN) OR OF FASTING (LOW INSULIN) ON SOME METABOLIC PROCESSES IN LIVER, MUSCLE AND ADIPOSE TISSUE
HIGH PLASMA INSULIN (POSTPRANDIAL STATE)
LOW PLASMA INSULIN (FASTED STATE)
Liver Glucose uptake Glucose production
Glycogen syntheses Glycogenolysis
Absence of gluconeogenesis Gluconeogenesis
Lipogenesis Absence of lipogenesis
Absence of ketogenesis Ketogenesis
Muscle Glucose uptake Absence of glucose uptake
Glucose oxidation Fatty acid and ketone oxidation
Glycogen synthesis Glycogenolysis
Protein synthesis Proteolysis and amino acid release
Adipose Tissue Glucose uptake Absence of glucose uptake
Lipid synthesis Lipolysis and fatty acid release
Triglyceride uptake Absence of triglyceride uptake 32
![Page 33: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/33.jpg)
PATHOPHYSIOLOGY
Insulin deficiency exaggerates the normal response to fasting: gluconeogenesis and glycogenolysis.
Peripheral glucose uptake is impaired and levels of the main counter-regulatory hormones increase (glucagon, cortisol, catecholamines, growth hormone).
A variety of metabolic consequences follow. 33
![Page 34: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/34.jpg)
Secondary to insulin deficiency and the action of counter-regulatory hormones (glucagon), blood glucose increases due to glycogenolysis and gluconeogenesis, leading to hyperglycemia and glucosuria.
Blood glucose levels rise above the renal threshold for glucose reabsorption, causing an osmotic diuresis, leading to waterwater & electrolyte loss.
In the absence of insulin activity the body fails to utilize glucose as fuel and uses fats instead. This leads to ketosis.
34
![Page 35: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/35.jpg)
The excess of ketone bodies will cause metabolic acidosis, the latter is also aggravated by lactic acidosis caused by dehydration & poor tissue perfusion.
Vomiting due to an ileus, plus increased insensible water losses due to tachypnea will worsen the state of dehydration.
Electrolyte abnormalities are secondary to their loss in urine & trans-membrane alterations following acidosis & osmotic diuresis.
35
![Page 36: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/36.jpg)
Because of acidosis, K+ ions enter the circulation leading to hyperkalemia, this is aggravated by dehydration and renal failure.
Depending on the duration of DKA, serum K+ at diagnosis may be high, normal or low, but the intracellular K+ stores are always depleted.
Phosphate depletion will also take place due to metabolic acidosis.
Na+ loss occurs secondary to the hyperosmotic state & the osmotic diuresis. 36
![Page 37: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/37.jpg)
The dehydration can lead to decreased kidney perfusion and acute renal failure.
Accumulation of ketone bodies contributes to the abdominal pain and vomiting.
The increasing acidosis leads to acidotic breathing and acetone smell in the breath and eventually causes impaired consciousness and coma.
37
![Page 38: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/38.jpg)
Fluid and electrolytes
Fluid losses are considerable, typically 3-10% of body weight.
Most water is lost by osmotic diuresis, with important contributions from hyperventilation and vomiting.
The diuresis also leads to considerable urinary losses of potassium, sodium, phosphate, and magnesium ions
38
![Page 39: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/39.jpg)
Ketoacidosis
Insulin inhibits the lipolytic action of cortisol and growth hormone, so insulin deficiency increases circulating levels of fatty acids.
These are oxidized in the liver, producing the acidic ketone bodies: beta-hydroxybutyrate and acetoacetate, from which acetone spontaneously forms.
The resulting acidosis primarily is due to circulating ketone bodies, with a smaller contribution from excess fatty acids and lactic acidosis, as a consequence of poor tissue perfusion. 39
![Page 40: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/40.jpg)
Absolute insulin deficiency ORStress, infection or insufficient insulin intake
Counter-regulatory hormones: Glucagon, Cortisol,Catecholamines, GH
Lipolysis
FFA to liver
Ketogenesis
Alkali reserve
Acidosis
Lactate
Glucose utilization
Proteolysis Protein synthesis
Glycogenolysis
Gluconeogenic substrates
Gluconeogenesis
Hyperglycemia
Glucosuria (osmotic diuresis)
Loss of water and electrolytes
Dehydration
Impaired renal function
Hyperosmolarity
40
![Page 41: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/41.jpg)
Clinical Presentation
Features of DKA are progressive. Symptoms are aggravated by presence of some
precipitating factors. Inter current infections Drugs e.g steroids, thiazides, terbutaline, dobutamine Psychological stress Trauma Alcohol and drug abuse Insulin omission in already diagnosed diabetics
41
![Page 42: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/42.jpg)
Features include:
Polyuria- nocturiaNocturnal enuresisPolydipsiaHyperphagiaWeight lossVaginitisMuscle cramps and pains
42
![Page 43: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/43.jpg)
Abdominal discomfort or painNausea, vomitingDehydration- moderate to severeDeep, heavy and rapid breathing- Kussmaul’ s
breathingFruity acetone breathLethargyAltered mental state from disorientation to coma
43
![Page 44: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/44.jpg)
Diagnosis – Cardinal Features
44
![Page 45: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/45.jpg)
DKA can present;ShockDehydration with no shockPresence of complicationsPresence of cardinal features otherwise stable
45
![Page 46: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/46.jpg)
Classification of DKAMild Moderate Severe
HCO3 (mmol/L)
10-15 5-10 <5
CO2 (mEq/L)
16 - 20 10 - 15 < 10
pH 7.25 – 7.35 7.15 – 7.25 < 7.15
Clinical state Oriented, alert but fatigued
Oriented but sleepy; arousable; Kussmaul respiration
Kussmaul or depressed respiration; sleepy to depressed sensorium to coma
46
![Page 47: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/47.jpg)
Work up
Plasma glucose – hyperglycemia HbA1c Serum ketone assay Urinalysis – glucosuria, ketonuria, evidence of
infection E, U, Cr – K+, Na+, HCO3, PO4, elevated BUN Arterial Blood gases – acidosis FBC – infection Malaria parasite, Cultures – infection ECG
47
![Page 48: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/48.jpg)
Insulin / Islet cell AntibodiesThyroid function tests/ thyroid auto
antibodiesBrain CTAbdominal X rays/ Abdominal USS
48
![Page 49: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/49.jpg)
Differential Diagnosis
1. Non-ketotic Hyperosmolar Coma/ HHS2. Urinary tract infection3. Acute gastroenteritis with dehydration4. Acute pancreatitis5. Acute abdomen6. Meningitis7. ARI – pneumonia, bronchiolitis8. Status asthmaticus9. Hysterical hyperventilation
49
![Page 50: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/50.jpg)
50
![Page 51: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/51.jpg)
Complications
1. Cerebral edema
2. Intracranial infarction
3. Cerebral venous thrombosis
4. Acute Tubular Necrosis
5. Deep Venous Thrombosis
6. Pulmonary edema
7. Electrolyte derangement(s)
8. Cardiac dysrhythmias51
![Page 52: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/52.jpg)
Cerebral Edema
Occurs in 0.5 – 1% of children.Accounts for 90% of neurological complications of
DKACarries a high mortality risk – 70%. Only about 15% recover without sequelae.Typically occurs 6 – 10 hours after initiation of
treatment. It often follows a period of clinical improvement.Can occur prior to therapy.
52
![Page 53: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/53.jpg)
Mechanism not fully understood but few theories-Loss of cerebral autoregulationVasogenic mechanism of edema formation.Cerebral ischemia
53
![Page 54: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/54.jpg)
Risk factors
Younger age - < 5 yearsRapid rehydrationProlonged duration of symptoms prior to
therapyAdministration of IV bicarbonateHigh initial glucose concentrationHypernatremia or persistent hyponatremia.
54
![Page 55: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/55.jpg)
Clinical features
Headache, lethargy, confusionPupillary changesIncontinenceDeteriorating consciousnessSeizuresCushings triad – hypertension,
bradycardia, irregular respiration
55
![Page 56: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/56.jpg)
Diagnosis
Based on a single criterion:Decorticate or decerebrate postureCranial nerve palsy – iii, iv, viAbnormal respirationAbnormal verbal or motor response to pain
56
![Page 57: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/57.jpg)
Major CriteriaAltered mental stateBradycardiaIncontinence
57
![Page 58: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/58.jpg)
Minor Criteria:VomitingHeadacheLethargyHypertension DBP> 90mmHgAge < 5
2 major, or 1 major + 2 minor58
![Page 59: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/59.jpg)
Treatment of DKA
DKA is an emergency; but, it is managed with cautious urgency
Treatment of DKA requires frequent eyes-on, hands-on and brain-on reassessment
It should never be “auto-pilot” or managed from the call room
Team consultant must be informed
![Page 60: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/60.jpg)
Emergency assessment + Resuscitation
Quick history
Weigh the child/ estimate
Assess consciousness (Glasgow Coma Scale)
Bedside tests ( RBS, Urinalysis, PO2)
![Page 61: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/61.jpg)
Examination
General state/level of consciousness
Level of hydration (usually overestimated)3% -just detectable5% -dry mucus membranes/reduced skin
tugor8%-slow cap. Refill(>3sec)/sunken eyes>10%-shock, weak pulses, ↓BP
![Page 62: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/62.jpg)
Respiration HyperventilationIrregular in cerebral edemaCongestion/consolidationCardiovascular Low volume/thready pulseTachycardiaBradycardia in ↓ ICP
![Page 63: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/63.jpg)
EyesPapilloedema
Abdomen TendernessReduced bowel sounds (ileus)
![Page 64: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/64.jpg)
Resuscitation
Airway SuctionOropharyngeal airwayNG tube for gastric emptyingBreathing 100% O2 by face mask
CirculationInsert iv canula; collect all blood samples
![Page 65: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/65.jpg)
Modalities
Fluid replacement
Electrolyte replacement
Insulin infusion
Treatment of infections
Correct complications
Monitoring
![Page 66: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/66.jpg)
Fluid replacement
Deficit + maintenance
Correction of deficit: 10-20ml/kg in 1st hr IVF N/S OR Ringer’s bolus (max 3 doses
in shock)
Maintenance + remainder of deficit over 48hrs
IVF N/S Change to 0.45% saline + 5% DW (when
RBS ≤ 15 mmol/L)
![Page 67: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/67.jpg)
Age (yrs) Weight (kg)
Maintenance fluid/24hr
< 1 3-9 80
1-5 10-19 70
6-9 20-29 60
10-14 30-50 50
> 15 > 50 35
![Page 68: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/68.jpg)
Fluid calculation
Deficit= estimated% dehydration x wt x 10 (mls)
Maintenance= wt x 100ml/kg (1st 10kg)+50ml/kg (2nd 10kg)+20ml/kg (subsequent kg)
Example; 20kg child, 10% dehydratedDeficit= 10x 20 x10 = 2000 mlMaintenance= 20 x 60= 1200 x2=2400/48hrsTotal fluids over 48hr= 4800ml @ 33dpm
![Page 69: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/69.jpg)
Electrolyte replacement
Electrolyte depleted in DKA include; K+,Na+ PO4, and Mg2+
Total body K+ always depleted in DKA (≈4-6mmol/kg)
initial level of K+ may be low, normal or high
K ⁺ Should not be started until shock is corrected
Requires ECG monitoring
![Page 70: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/70.jpg)
Rate of infusion is usually 3mmol/kg/24hr (max dose 0.5mmol/kg/hr)
Hypokalemia; give after initial fluid resuscitation
20mmol/L
Eukalemia; at the time of insulin introduction
40mmol/L (20 as KCl, 20 as KPO4)
Hyperkalemia; when patient makes urine
![Page 71: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/71.jpg)
Insulin
Insulin is required to reverse the metabolic abnormalities by further decreasing blood glucose and inhibiting ketone body formation.
Only give when shock has been reversed
Usually started in the 2nd hr of management
Optimal method is by continuous low dose intravenous infusion (via pump)
![Page 72: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/72.jpg)
Recommended initial dose is 0.1U/kg/hr of soluble insulin
Subcutaneous insulin 0.3U/kg stat, then 0.1U/kg/hr if iv access not possible: provided good peripheral circulation
Insulin can be reduced to 0.05U/kg/hr (if pH > 7.3, HCO3
-1, rate of fall of glucose > 5mmo/L/hr)
If RBS falls to < 4mmol/L (give 2ml/kg of 10% DW bolus)
![Page 73: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/73.jpg)
Insulin Therapy
10 units of short-acting Insulin with 0.9%saline into a soluset/syringe pump to make up 100ml, producing a concentration of 1U/10mlE.g. a seven year old weighing 30kg requiring 0.1U/kg/hour of insulin0.1 x 30 = 3U/hourSince 10ml=1U, then 3U/hour = 30ml/hour60drops = 1mlHence 30 x 60 = 1800drops/hour (60mins =1hour)30 drops/minute
![Page 74: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/74.jpg)
Correction of acidosis
Usually autocorrected by IVF and insulin administration ( improved GFR)
NaHCO3 is given cautiously if there is;
pH< 6.9HCO3
-1 < 5mmol/L
Given empirically at dose of 1-2mmol/kg over 1hr as infusion
![Page 75: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/75.jpg)
Treat infections
Commonest precipitant of DKA
Usually started empirically until blood culture is available
May include treatment for malaria, pneumonia, meningitis etc as appropriate
![Page 76: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/76.jpg)
Monitoring treatment complicationsCerebral edemaMajor cause of mortalityComplicated by early commencement of
insulinOverzealous rehydration also a culpritAlso implicated is correction of acidosis
with NaHCO₃Severe hyperglycemia with high
osmolality (Sosm >350 mOsm /L)
![Page 77: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/77.jpg)
Treatment includes;
Reduction of IVF to ½ or 2/3rd of maintenance
Elevate head 30 to the horizontal⁰
IV mannitol 0.5-1g/kg/dose 6-8hrly (iv furosemide as adjunct)
IV 3% (hypertonic) saline 2-4ml/kg alternative
Hyperventilation
Dialysis
![Page 78: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/78.jpg)
Hypoglycemia
Usually caused by high insulin doses/bolus injections
Prevented by regular blood sugar monitoring while patient is on insulin infusion
Corrected by giving 2-4ml/kg of iv 10% DW bolus, continuing ivf 0.45% saline + 5% DW (which may be increased to 10% DW)
Dose of insulin infusion may be reduced by 0.025U up to 0.5U/kg/hr
![Page 79: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/79.jpg)
Cardiac dysrhythmia
Usually secondary to hypokalemia /acidosis
Need for cardiac monitoring
Usually corrected when cause is treated
![Page 80: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/80.jpg)
Monitoring
Neurological assessment: ½ -1hourly
Vital signs: Pulse rate, respiratory rate BP - hourly
Strict intake / output chart
Random blood sugar & urine/blood ketones hourly
Electrolytes: initially 2hourly. When K and Na are normal and HCO₃ > 15mmol/L 4-6 hourly ⁻
![Page 81: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/81.jpg)
Transition to subcutaneous insulin
When dehydration, acidosis and hyperglycemia are corrected
Blood ketone levels are low (<1mmol/L)
Patient is tolerating orally, no longer vomiting
Target blood sugar before commencement 8.3-13.8 mmol/L
![Page 82: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/82.jpg)
Dose; 0.5-0.7U/kg/dose of soluble insulin 8 hourly
Dose up to 1.0U/kg/day of mixtard on discharge
< 30kg: 0.3U/kg/day; 2/3rd AM,1/3rd PM > 30kg: 0.6U/kg/day; 2/3rd AM, 1/3rd PMStop insulin infusion ½ to 1hour after
commencement of subcutaneous injection
![Page 83: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/83.jpg)
Counseling for discharge
Treatment is lifelong Educating patient and family members on:Basic pathophysiology of DMImportance of adequate control to avoid
complicationsSurvival skills:How to check/monitor blood glucoseMonitor urine glucose and ketonesPreparation and injection of insulinHow to recognize hypoglycemia and hyperglycemiaHow to plan meals
![Page 84: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/84.jpg)
Long term monitoring
HbAIC; Normal < 6%:In diabetics;6-7.9: good control8.0-9.9: fair control>10: poor control
Early treatment of infections/injuriesGrowth monitoring
![Page 85: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/85.jpg)
Regular eye check
Renal status check
Regular neurological checks
Cardiovascular assessment: BP, arterial wall thickness
![Page 86: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/86.jpg)
04/15/23 86
![Page 87: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/87.jpg)
|
![Page 88: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/88.jpg)
Prevention
General Health Promotion: enlightenmentSpecific preventionEarly diagnosis and treatmentLimitation of disabilityRehabilitation
88
![Page 89: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/89.jpg)
Conclusion
DKA is a common complication of paediatric diabetes melitus
It carries significant risk of death and/or morbidity especially with delayed treatment
High index of suspicion is required for early detection and treatment
Treatment is done with cautious urgency in order to forestall complications of treatment
89
![Page 90: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/90.jpg)
References
Nelson Textbook of Paediatrics, 19th EditionMedscape: Paediatric Diabetes MellitusPaediatric Management of Paediatric DKA;
Guidline No. 13; 3rd Edition by Dr. Carrihill and Greening
BSPED Recommended DKA Guidelines 2013Endocrinology update 2012/2013
90
![Page 91: DKA FINAL](https://reader036.vdocument.in/reader036/viewer/2022062304/55c463c4bb61eb49248b4575/html5/thumbnails/91.jpg)
Thank You!
91